Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_33637 | 187 | 3.90 | Mlig455_027211, Mlig455_027458 | Neo: - Age: - Region-enriched R2: 3.458/0.04514 |
CHRNA10, CHRNA7 | Mlig455_027211 {REF} {Length: 782} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=89.4, Expect=4e-20]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=89.4, Expect=4e-20]; ENSG00000166664, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=2e-20]; ENSG00000275917, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=1e-20]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=92.0, Expect=4e-21]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=81.6, Expect=9e-18]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=71.6, Expect=2e-14]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=86.3, Expect=1e-19]} {RNA1310_19147.2} {RNA815_8553.2} Mlig455_027458 {REF} {Length: 1493} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.5]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=149, Expect=1e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=133, Expect=5e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=6e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=144, Expect=7e-38]} {RNA1310_19147.2} {RNA815_8553.2} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 2.08 | 2.548 | 0.30261 | 0.95237 | |
RegionR2 | 3.458 | 2.548 | 0.00290 | 0.04514 | |
RegionR3 | 1.332 | 2.548 | 0.18149 | 0.71375 | |
RegionR4 | 0.206 | 2.548 | 0.75117 | 1.00000 | |
RegionR5 | -1.554 | 2.548 | 0.99730 | 1.00000 | |
RegionR6 | -1.952 | 2.548 | 0.99888 | 1.00000 | |
RegionR7 | 0.811 | 2.548 | 0.49117 | 1.00000 | |
RegionR8 | -4.381 | 2.548 | 0.23052 | 0.84346 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -6.606 | 2.548 | 0.19009 | 0.93000 | |
RegenerationR2 | -0.721 | 2.548 | 0.43135 | 0.83470 | |
RegenerationR3 | -0.41 | 2.548 | 0.66877 | 0.93630 | |
RegenerationR4 | -1.042 | 2.548 | 0.41618 | 0.82401 | |
RegenerationR5 | 0.27 | 2.548 | 0.77677 | 0.98073 | |
RegenerationR6 | -0.777 | 2.548 | 0.68805 | 0.91767 | |
RegenerationBL | -3.402 | 2.548 | 0.99982 | 1.00000 | |
RegenerationTP | 2.392 | 2.548 | 0.28457 | 0.73138 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_33637 | 187 | 3.9 | Mlig455_027211, Mlig455_027458 | Neo: - Age: - Region-enriched R2: 3.458/0.04514 |
CHRNA10, CHRNA7 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_027211 {REF} {Length: 782} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=89.4, Expect=4e-20]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=89.4, Expect=4e-20]; ENSG00000166664, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=2e-20]; ENSG00000275917, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=1e-20]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=92.0, Expect=4e-21]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=81.6, Expect=9e-18]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=71.6, Expect=2e-14]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=86.3, Expect=1e-19]} {RNA1310_19147.2} {RNA815_8553.2} Mlig455_027458 {REF} {Length: 1493} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.5]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=149, Expect=1e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=133, Expect=5e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=6e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=144, Expect=7e-38]} {RNA1310_19147.2} {RNA815_8553.2} |
2. | MligTC455_19275 | 407 | 8.47 | Mlig455_037548 | Neo: - Age: logFC(26M/2M)=0.488 Region-enriched R2: 3.247/0.04164 |
CHRNA10 | 5.265 | 0.842 | 0.961 | 0.941 | 0.747 | 0.816 | 0.958 | Mlig455_037548 {REF} {Length: 959} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=87.9]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=96.7, Expect=1e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=97.1, Expect=7e-23]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=95.1, Expect=5e-22]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=1e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=119, Expect=8e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=93.2, Expect=1e-21]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1} |
3. | MligTC455_19278 | 4335 | 90.31 | Mlig455_057304, Mlig455_070944 | Neo: - Age: logFC(26M/2M)=0.686 Region-specific R2: 5.590 Region-enriched R2: 5.465/0.00000 |
CHRNA10 | 4.308 | - | 0.970 | 0.761 | 0.837 | 0.782 | 0.958 | Mlig455_057304 {REF} {Length: 1001} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=71.6]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=77.0, Expect=2e-16]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=75.9, Expect=4e-16]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=75.5, Expect=6e-16]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=73.9, Expect=2e-15]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=93.6, Expect=2e-22]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=100, Expect=5e-25]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=82.8, Expect=8e-19]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1} Mlig455_070944 {REF} {Length: 1060} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=88.2]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=95.9, Expect=6e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=96.3, Expect=3e-22]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=94.7, Expect=1e-21]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=112, Expect=7e-28]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=118, Expect=4e-30]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=98.6, Expect=2e-23]} {RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1310_34970, RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1509_23115, RNA1509_43907, RNA1509_9432, RNA815_15305.1} |
4. | MligTC455_19280 | 21417 | 446.19 | Mlig455_057387, Mlig455_059547 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.621 Region-enriched R2: 3.570/0.00141 |
CHRNA10 | 4.276 | - | 0.963 | 0.726 | 0.790 | 0.839 | 0.958 | Mlig455_057387 {REF} {Length: 1088} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=87.8]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=95.5, Expect=6e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=95.5, Expect=4e-22]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=94.7, Expect=1e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=94.0, Expect=2e-21]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=109, Expect=6e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=8e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=97.4, Expect=5e-23]} {RNA1509_1306, RNA1509_1333, RNA1509_15501} {RNA1310_34970, RNA1509_1333, RNA1509_15501} {RNA1509_1333, RNA1509_15501, RNA815_15305.1} Mlig455_059547 {REF} {Length: 1084} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=85.3]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=91.3, Expect=1e-20]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=92.0, Expect=7e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=88.2, Expect=1e-19]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=2e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=4e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=96.3, Expect=8e-23]} {RNA1509_1306} {RNA1310_34970} {RNA815_15305.1} |
5. | MligTC455_39988 | 83 | 1.73 | Mlig455_062081 | Neo: - Age: - |
4.224 | 0.970 | 0.724 | - | 0.727 | 0.900 | 0.903 | Mlig455_062081 {REF} {Length: 447} {NoTransDecoderORF} {RNA1509_50426} {RNA1310_88257} {RNA815_17173.4} | |
6. | MligTC455_40878 | 355 | 7.39 | Mlig455_014130 | Neo: - Age: - |
4.117 | 0.748 | 0.727 | 0.963 | 0.723 | - | 0.956 | Mlig455_014130 {REF} {Length: 1465} {RNA1509_7458} {RNA1310_36212} {RNA815_1610.1} | |
7. | MligTC455_51194 | 408 | 8.5 | Mlig455_007624, Mlig455_007645 | Neo: - Age: - Region-specific R2: 3.993 Region-enriched R2: 3.717/0.00015 |
CDK5R1 | 3.572 | 0.955 | 0.868 | 0.907 | - | - | 0.842 | Mlig455_007624 {REF} {Length: 1990} {Pfam: Cyclin-dependent kinase 5 activator protein [PF03261.17, score=249.2]} {Human: ENSG00000176749, CDK5R1, cyclin dependent kinase 5 regulatory subunit 1, [RH, Score=191, Expect=7e-57]} {Mouse: ENSMUSG00000048895, Cdk5r1, cyclin-dependent kinase 5, regulatory subunit 1 (p35), [RH, Score=191, Expect=6e-57]} {Dmel: FBgn0027491, Cdk5alpha, Cdk5 activator-like protein, [RH, Score=199, Expect=2e-58]} {Celegans: WBGene00011955, cdka-1, Cyclin-dependent kinase 5 activator 1, [RH, Score=176, Expect=6e-51]} {Smed: dd_Smed_v6_13788_0_1, dd_Smed_v6_13788_0_1, [RH, Score=215, Expect=1e-66]} {RNA1509_28436} {RNA1310_14097} {RNA815_13436} Mlig455_007645 {REF} {Length: 1937} {Pfam: Cyclin-dependent kinase 5 activator protein [PF03261.17, score=249.3]} {Human: ENSG00000176749, CDK5R1, cyclin dependent kinase 5 regulatory subunit 1, [RH, Score=191, Expect=8e-57]} {Mouse: ENSMUSG00000048895, Cdk5r1, cyclin-dependent kinase 5, regulatory subunit 1 (p35), [RH, Score=191, Expect=5e-57]} {Dmel: FBgn0027491, Cdk5alpha, Cdk5 activator-like protein, [RH, Score=199, Expect=3e-58]} {Celegans: WBGene00011955, cdka-1, Cyclin-dependent kinase 5 activator 1, [RH, Score=177, Expect=2e-51]} {Smed: dd_Smed_v6_13788_0_1, dd_Smed_v6_13788_0_1, [RH, Score=216, Expect=1e-66]} {RNA1509_28436} {RNA1310_14097} {RNA815_13436} |
8. | MligTC455_24162 | 48 | 1 | Mlig455_014024 | Neo: - Age: - |
3.569 | 0.987 | - | - | 0.760 | 0.946 | 0.876 | Mlig455_014024 {REF} {Length: 3118} {RNA1310_27501} {RNA815_14263} | |
9. | MligTC455_19276 | 1694 | 35.28 | Mlig455_057303 | Neo: - Age: Down-Down-Up Region-specific R2: 5.711 Region-enriched R2: 6.117/0.00000 |
3.533 | - | 0.967 | - | 0.834 | 0.774 | 0.958 | Mlig455_057303 {REF} {Length: 1196} {Pfam: TATA-binding related factor (TRF) of subunit 20 of Mediator complex [PF08612.13, score=80.6]} {Smed: dd_Smed_v6_9879_0_1, dd_Smed_v6_9879_0_1, [RH, Score=73.9, Expect=1e-15]} {RNA1509_58478} {RNA1310_35292} {RNA815_20171} | |
10. | MligTC455_40851 | 132 | 2.76 | Mlig455_042077 | Neo: - Age: logFC(26M/2M)=0.724 Region-enriched R2: 3.969/0.02676 |
PKD1L2 | 3.524 | 0.902 | 0.800 | 0.975 | - | - | 0.847 | Mlig455_042077 {REF} {Length: 4836} {Pfam: PLAT/LH2 domain [PF01477.25, score=68.6]; Polycystin cation channel [PF08016.14, score=53.9]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [Score=220, Expect=3e-58]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=212, Expect=7e-56]} {Dmel: FBgn0050048, CG30048, [Score=55.8, Expect=2e-07]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=122, Expect=1e-27]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=328, Expect=2e-94]} {RNA1509_8046} {RNA1310_93} {RNA815_1216} |
11. | MligTC455_37720 | 156 | 3.25 | Mlig455_027725, Mlig455_027921, Mlig455_027931 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.630/0.03113 |
TRPV6 | 3.502 | 0.817 | 0.825 | 0.979 | - | - | 0.881 | Mlig455_027725 {REF} {Length: 5690} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=53.7]; Ion transport protein [PF00520.33, score=39.6]; Ankyrin repeat [PF13606.8, score=33.0]; Ankyrin repeats (many copies) [PF13857.8, score=30.8]; Ankyrin repeat [PF00023.32, score=29.7]; Polycystin cation channel [PF08016.14, score=27.5]; Ankyrin repeats (many copies) [PF13637.8, score=21.3]} {Human: ENSG00000165125, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=207, Expect=4e-55]; ENSG00000276971, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=206, Expect=4e-55]} {Mouse: ENSMUSG00000029868, Trpv6, transient receptor potential cation channel, subfamily V, member 6, [Score=206, Expect=1e-54]} {Dmel: FBgn0086693, iav, inactive, [RH, Score=568, Expect=0.0]} {Celegans: WBGene00003889, osm-9, Olfactory channel, [RH, Score=489, Expect=8e-156]} {Smed: dd_Smed_v6_28914_0_1, dd_Smed_v6_28914_0_1, [Score=492, Expect=6e-158]} {RNA1509_36869} {RNA1310_5278, RNA1509_36869} {RNA1509_36869, RNA815_5723} Mlig455_027921 {REF} {Length: 8298} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=53.7]; Ion transport protein [PF00520.33, score=39.2]; Ankyrin repeat [PF13606.8, score=33.0]; Ankyrin repeats (many copies) [PF13857.8, score=30.8]; Ankyrin repeat [PF00023.32, score=29.8]; Polycystin cation channel [PF08016.14, score=27.1]; Ankyrin repeats (many copies) [PF13637.8, score=21.3]} {Human: ENSG00000165125, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=207, Expect=4e-55]; ENSG00000276971, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=206, Expect=5e-55]} {Mouse: ENSMUSG00000029868, Trpv6, transient receptor potential cation channel, subfamily V, member 6, [Score=206, Expect=9e-55]} {Dmel: FBgn0086693, iav, inactive, [RH, Score=566, Expect=0.0]} {Celegans: WBGene00003889, osm-9, Olfactory channel, [RH, Score=488, Expect=1e-155]} {Smed: dd_Smed_v6_28914_0_1, dd_Smed_v6_28914_0_1, [Score=491, Expect=1e-157]} {RNA1509_36869} {RNA1310_5278} {RNA815_5723} Mlig455_027931 {REF} {Length: 6147} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=53.7]; Ion transport protein [PF00520.33, score=40.0]; Ankyrin repeat [PF13606.8, score=34.3]; Ankyrin repeats (many copies) [PF13857.8, score=31.5]; Ankyrin repeat [PF00023.32, score=30.2]; Polycystin cation channel [PF08016.14, score=27.8]; Ankyrin repeats (many copies) [PF13637.8, score=21.7]} {Human: ENSG00000276971, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=208, Expect=7e-56]; ENSG00000165125, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=207, Expect=1e-55]} {Mouse: ENSMUSG00000029868, Trpv6, transient receptor potential cation channel, subfamily V, member 6, [Score=206, Expect=3e-55]} {Dmel: FBgn0086693, iav, inactive, [RH, Score=567, Expect=0.0]} {Celegans: WBGene00003889, osm-9, Olfactory channel, [RH, Score=488, Expect=5e-157]} {Smed: dd_Smed_v6_28914_0_1, dd_Smed_v6_28914_0_1, [Score=490, Expect=4e-159]} {RNA1509_36869} {RNA1310_5278} {RNA815_5723} |
12. | MligTC455_19277 | 1013 | 21.11 | Mlig455_059600 | Neo: - Age: - Region-specific R2: 4.883 Region-enriched R2: 5.766/0.00000 |
3.5 | - | 0.960 | - | 0.770 | 0.801 | 0.969 | Mlig455_059600 {REF} {Length: 827} {NoTransDecoderORF} {RNA1509_43907} {RNA1310_81348} | |
13. | MligTC455_19279 | 4576 | 95.33 | Mlig455_057411 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.654 Region-specific R2: 5.173 Region-enriched R2: 4.585/0.00000 |
CHRNA10 | 3.48 | - | 0.952 | - | 0.772 | 0.789 | 0.967 | Mlig455_057411 {REF} {Length: 1075} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=85.3]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=91.3, Expect=1e-20]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=92.0, Expect=7e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=88.2, Expect=1e-19]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=2e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=4e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=96.3, Expect=8e-23]} {RNA1509_1306} {RNA1310_34970} {RNA815_15305.1} |
14. | MligTC455_34738 | 836 | 17.41 | Mlig455_032157, Mlig455_032163, Mlig455_067631 | Neo: - Age: - |
3.445 | - | 0.769 | 0.959 | - | 0.763 | 0.954 | Mlig455_032157 {REF} {Length: 1841} {Pfam: Stathmin family [PF00836.21, score=49.5]} {Smed: dd_Smed_v6_512_0_1, dd_Smed_v6_512_0_1, [RH, Score=80.5, Expect=2e-21]} {RNA1509_18048, RNA1509_6791} {RNA1310_32272, RNA1509_18048, RNA1509_6791} {RNA1509_18048, RNA1509_6791, RNA815_831} Mlig455_032163 {REF} {Length: 1001} {Pfam: Stathmin family [PF00836.21, score=44.6]} {Smed: dd_Smed_v6_512_0_1, dd_Smed_v6_512_0_1, [RH, Score=84.0, Expect=3e-22]} {RNA1509_6791} {RNA1310_71333} {RNA815_831} Mlig455_067631 {REF} {Length: 817} {Pfam: Stathmin family [PF00836.21, score=31.3]} {RNA1509_6791} {RNA1310_71333} {RNA815_831} |
|
15. | MligTC455_35894 | 23 | 0.48 | Mlig455_029906 | Neo: - Age: - |
RYK | 3.444 | 0.989 | - | - | 0.781 | 0.726 | 0.948 | Mlig455_029906 {REF} {Length: 3571} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=210.1]; WIF domain [PF02019.20, score=110.2]; Protein kinase domain [PF00069.27, score=79.8]} {Human: ENSG00000163785, RYK, receptor-like tyrosine kinase, [Score=202, Expect=7e-57]} {Mouse: ENSMUSG00000032547, Ryk, receptor-like tyrosine kinase, [Score=202, Expect=9e-57]} {Dmel: FBgn0015380, drl, derailed, [RH, Score=241, Expect=7e-71]} {Celegans: WBGene00003007, lin-18, Inactive tyrosine-protein kinase RYK, [RH, Score=179, Expect=9e-49]} {Smed: dd_Smed_v6_12594_0_3, dd_Smed_v6_12594_0_3, [Score=201, Expect=2e-56]} {RNA1509_58811} {RNA1310_6671.2, RNA1509_58811} {RNA1509_58811, RNA815_41921} |
16. | MligTC455_27650 | 178 | 3.72 | Mlig455_017720 | Neo: - Age: logFC(26M/2M)=-0.928 Region-enriched R2: 3.586/0.00082 |
ADAM33 | 3.439 | 0.955 | 0.793 | - | - | 0.769 | 0.922 | Mlig455_017720 {REF} {Length: 4499} {Pfam: Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=124.3]; Disintegrin [PF00200.25, score=66.8]; Metallo-peptidase family M12 [PF13688.8, score=62.2]; ADAM cysteine-rich [PF08516.14, score=61.3]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=33.1]} {Human: ENSG00000149451, ADAM33, ADAM metallopeptidase domain 33, [Score=237, Expect=1e-64]; ENSG00000151651, ADAM8, ADAM metallopeptidase domain 8, [Score=233, Expect=2e-63]; ENSG00000168615, ADAM9, ADAM metallopeptidase domain 9, [Score=230, Expect=2e-62]; ENSG00000148848, ADAM12, ADAM metallopeptidase domain 12, [Score=228, Expect=4e-61]; ENSG00000069206, ADAM7, ADAM metallopeptidase domain 7, [Score=226, Expect=4e-61]; ENSG00000042980, ADAM28, ADAM metallopeptidase domain 28, [Score=226, Expect=4e-61]} {Mouse: ENSMUSG00000079058, Adam34, a disintegrin and metallopeptidase domain 34, [RH, Score=248, Expect=4e-69]; ENSMUSG00000050190, Gm5346, predicted gene 5346, [RH, Score=239, Expect=3e-66]} {Dmel: FBgn0265140, Meltrin, [RH, Score=288, Expect=1e-79]} {Celegans: WBGene00000074, adm-2, ADAM (Disintegrin plus metalloprotease) family, [Score=246, Expect=3e-67]} {Smed: dd_Smed_v6_5143_0_1, dd_Smed_v6_5143_0_1, [Score=225, Expect=3e-60]} {RNA1509_7654} {RNA1310_9319.1} {RNA815_4173.1} |
17. | MligTC455_13094 | 121 | 2.52 | Mlig455_005442, Mlig455_005513 | Neo: - Age: Up-Up-Down |
3.426 | 0.953 | 0.837 | 0.898 | 0.738 | - | - | Mlig455_005442 {REF} {Length: 3816} {Smed: dd_Smed_v6_15433_0_1, dd_Smed_v6_15433_0_1, [Score=141, Expect=1e-34]} {RNA1509_41201} {RNA1310_51044} {RNA815_32534} Mlig455_005513 {REF} {Length: 685} {NoTransDecoderORF} {RNA1310_56412} {RNA815_32534} |
|
18. | MligTC455_29408 | 45 | 0.94 | Mlig455_038322 | Neo: - Age: - Region-enriched R2: 8.586/0.00762 |
MB | 3.387 | 0.962 | 0.749 | - | 0.758 | - | 0.918 | Mlig455_038322 {REF} {Length: 2059} {Pfam: Globin [PF00042.24, score=57.8]} {Human: ENSG00000198125, MB, myoglobin, [RH, Score=47.8, Expect=5e-07]} {Mouse: ENSMUSG00000018893, Mb, myoglobin, [RH, Score=45.4, Expect=2e-06]} {Celegans: WBGene00008996, glb-14, GLoBin related, [Score=51.6, Expect=4e-08]} {Smed: dd_Smed_v6_15997_0_1, dd_Smed_v6_15997_0_1, [RH, Score=63.5, Expect=1e-12]} {RNA1509_48898} {RNA1310_47695} {RNA815_7096.1} |
19. | MligTC455_29914 | 44 | 0.91 | Mlig455_027923 | Neo: - Age: Down-Up-Down Region-enriched R2: 8.096/0.00455 |
ANGPTL3 | 3.385 | 0.964 | 0.711 | - | - | 0.769 | 0.941 | Mlig455_027923 {REF} {Length: 1663} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=70.5]} {Human: ENSG00000132855, ANGPTL3, angiopoietin like 3, [Score=60.5, Expect=9e-10]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=59.3, Expect=2e-09]; ENSG00000120332, TNN, tenascin N, [Score=58.9, Expect=3e-09]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=62.4, Expect=2e-10]} {Dmel: FBgn0031804, CG9500, [Score=76.3, Expect=6e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=51.2, Expect=3e-07]} {RNA1509_53291} {RNA1310_58974} {RNA815_43288.3} |
20. | MligTC455_43258 | 756 | 15.75 | Mlig455_027531 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=0.347 Region-enriched R2: 1.796/0.01868 Regeneration-downregulated BL: -3.121 Regeneration-depleted BL: -3.121 |
3.363 | 0.958 | 0.781 | 0.844 | - | - | 0.780 | Mlig455_027531 {REF} {Length: 695} {RNA1509_24629} {RNA1310_43299, RNA1509_24629} {RNA1509_24629, RNA815_28702} | |
21. | MligTC455_16415 | 197 | 4.1 | Mlig455_000401 | Neo: - Age: - Region-enriched R2: 4.276/0.00982 |
ROR1 | 3.309 | 0.963 | 0.726 | - | 0.726 | - | 0.894 | Mlig455_000401 {REF} {Length: 3780} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=233.3]; Protein kinase domain [PF00069.27, score=85.9]; Immunoglobulin I-set domain [PF07679.18, score=49.4]; Immunoglobulin domain [PF13927.8, score=46.6]; Immunoglobulin domain [PF00047.27, score=31.9]; Immunoglobulin domain [PF13895.8, score=30.0]; Fz domain [PF01392.24, score=27.6]; Kringle domain [PF00051.20, score=22.3]; Immunoglobulin V-set domain [PF07686.19, score=19.5]} {Human: ENSG00000185483, ROR1, receptor tyrosine kinase like orphan receptor 1, [RH, Score=390, Expect=1e-119]; ENSG00000169071, ROR2, receptor tyrosine kinase like orphan receptor 2, [RH, Score=379, Expect=1e-115]} {Mouse: ENSMUSG00000035305, Ror1, receptor tyrosine kinase-like orphan receptor 1, [RH, Score=386, Expect=1e-118]; ENSMUSG00000021464, Ror2, receptor tyrosine kinase-like orphan receptor 2, [RH, Score=377, Expect=4e-115]} {Dmel: FBgn0010407, Ror, [Score=286, Expect=3e-84]} {Celegans: WBGene00000289, cam-1, Tyrosine-protein kinase receptor cam-1, [Score=285, Expect=4e-82]} {Smed: dd_Smed_v6_7911_0_1, dd_Smed_v6_7911_0_1, [RH, Score=439, Expect=2e-139]} {RNA1509_35395} {RNA1310_13558, RNA1509_35395} {RNA1509_35395, RNA815_27446} |
22. | MligTC455_38355 | 110 | 2.29 | Mlig455_039715, Mlig455_039769 | Neo: - Age: - |
KCNB2 | 3.274 | 0.725 | 0.803 | 0.785 | - | - | 0.961 | Mlig455_039715 {REF} {Length: 3883} {Pfam: Ion transport protein [PF00520.33, score=114.4]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=43.6]} {Human: ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=218, Expect=3e-60]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=213, Expect=2e-60]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=213, Expect=7e-59]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=210, Expect=2e-59]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=7e-59]} {Mouse: ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=219, Expect=5e-61]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=218, Expect=1e-60]; ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=214, Expect=8e-61]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=213, Expect=6e-60]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=230, Expect=8e-67]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=236, Expect=3e-69]} {Smed: dd_Smed_v6_11886_0_1, dd_Smed_v6_11886_0_1, [RH, Score=592, Expect=0.0]} {RNA1509_22940} {RNA1310_17926} {RNA815_8687.1} Mlig455_039769 {REF} {Length: 4176} {Pfam: Ion transport protein [PF00520.33, score=116.7]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=43.6]; Polycystin cation channel [PF08016.14, score=20.7]} {Human: ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=219, Expect=8e-61]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=216, Expect=2e-61]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=215, Expect=2e-59]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=213, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=213, Expect=4e-60]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=210, Expect=4e-58]} {Mouse: ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=221, Expect=2e-61]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=219, Expect=4e-61]; ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=216, Expect=6e-62]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=215, Expect=6e-61]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=211, Expect=1e-58]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=231, Expect=2e-67]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=239, Expect=2e-70]} {Smed: dd_Smed_v6_11886_0_1, dd_Smed_v6_11886_0_1, [RH, Score=595, Expect=0.0]} {RNA1509_22940} {RNA1310_17926} {RNA815_8687.1} |
23. | MligTC455_43227 | 81 | 1.7 | Mlig455_040808, Mlig455_040907 | Neo: - Age: - |
3.262 | 0.966 | 0.733 | - | - | 0.818 | 0.745 | Mlig455_040808 {REF} {Length: 3396} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=18.5]} {RNA1310_94548} {RNA815_41738} Mlig455_040907 {REF} {Length: 3148} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=18.0]} {RNA1310_56531.1} {RNA815_41738} |
|
24. | MligTC455_28724 | 128 | 2.66 | Mlig455_017717 | Neo: - Age: Up-Down-Down |
ANK1 | 3.238 | 0.951 | 0.735 | - | 0.774 | - | 0.778 | Mlig455_017717 {REF} {Length: 9852} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=513.3]; Ankyrin repeats (many copies) [PF13637.8, score=459.4]; Ankyrin repeats (many copies) [PF13857.8, score=371.3]; Ankyrin repeat [PF13606.8, score=296.0]; Ankyrin repeat [PF00023.32, score=166.1]} {Human: ENSG00000029534, ANK1, ankyrin 1, [Score=149, Expect=4e-35]; ENSG00000065413, ANKRD44, ankyrin repeat domain 44, [Score=143, Expect=2e-33]} {Mouse: ENSMUSG00000014498, Ankrd52, ankyrin repeat domain 52, [Score=145, Expect=3e-34]; ENSMUSG00000031543, Ank1, ankyrin 1, erythroid, [Score=142, Expect=3e-33]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=142, Expect=3e-33]} {Dmel: FBgn0016920, nompC, no mechanoreceptor potential C, [Score=147, Expect=9e-35]} {Celegans: WBGene00006616, trp-4, TRP (Transient receptor potential) channel family, [Score=129, Expect=1e-29]} {Smed: dd_Smed_v6_5303_0_2, dd_Smed_v6_5303_0_2, [Score=171, Expect=7e-43]} {RNA1509_11517} {RNA1310_203} {RNA815_6981} |
25. | MligTC455_36618 | 545 | 11.35 | Mlig455_020301, Mlig455_020358 | Neo: - Age: logFC(26M/2M)=-0.435 Region-enriched R2: 3.072/0.00097 |
SLC7A6 | 3.238 | 0.959 | 0.779 | - | 0.716 | 0.784 | - | Mlig455_020301 {REF} {Length: 4137} {Pfam: Amino acid permease [PF13520.8, score=183.8]; Amino acid permease [PF00324.23, score=95.7]} {Human: ENSG00000103064, SLC7A6, solute carrier family 7 member 6, [RH, Score=421, Expect=7e-143]; ENSG00000155465, SLC7A7, solute carrier family 7 member 7, [RH, Score=412, Expect=1e-139]; ENSG00000103257, SLC7A5, solute carrier family 7 member 5, [RH, Score=410, Expect=1e-138]} {Mouse: ENSMUSG00000031904, Slc7a6, solute carrier family 7 (cationic amino acid transporter, y+ system), member 6, [RH, Score=419, Expect=2e-142]; ENSMUSG00000027737, Slc7a11, solute carrier family 7 (cationic amino acid transporter, y+ system), member 11, [RH, Score=413, Expect=3e-140]; ENSMUSG00000000958, Slc7a7, solute carrier family 7 (cationic amino acid transporter, y+ system), member 7, [RH, Score=410, Expect=4e-139]} {Dmel: FBgn0039844, CG1607, [RH, Score=467, Expect=2e-161]} {Celegans: WBGene00000002, aat-1, Amino Acid Transporter, [RH, Score=431, Expect=1e-147]} {Smed: dd_Smed_v6_2179_0_1, dd_Smed_v6_2179_0_1, [RH, Score=498, Expect=5e-174]} {RNA1509_26498} {RNA1310_9422, RNA1509_26498} {RNA1509_26498, RNA815_5493} Mlig455_020358 {REF} {Length: 3120} {Pfam: Amino acid permease [PF13520.8, score=147.1]; Amino acid permease [PF00324.23, score=74.6]} {Human: ENSG00000103064, SLC7A6, solute carrier family 7 member 6, [Score=346, Expect=6e-115]; ENSG00000155465, SLC7A7, solute carrier family 7 member 7, [Score=340, Expect=2e-112]} {Mouse: ENSMUSG00000031904, Slc7a6, solute carrier family 7 (cationic amino acid transporter, y+ system), member 6, [Score=340, Expect=9e-113]; ENSMUSG00000000958, Slc7a7, solute carrier family 7 (cationic amino acid transporter, y+ system), member 7, [Score=335, Expect=7e-111]; ENSMUSG00000027737, Slc7a11, solute carrier family 7 (cationic amino acid transporter, y+ system), member 11, [Score=325, Expect=6e-107]} {Dmel: FBgn0039844, CG1607, [Score=390, Expect=1e-132]} {Celegans: WBGene00000002, aat-1, Amino Acid Transporter, [Score=353, Expect=2e-118]} {Smed: dd_Smed_v6_7207_0_1, dd_Smed_v6_7207_0_1, [Score=416, Expect=3e-143]} {RNA1509_56112} {RNA1310_9422, RNA1509_56112} {RNA1509_56112, RNA815_5493} |
26. | MligTC455_19329 | 90 | 1.88 | Mlig455_068578 | Neo: - Age: - Region-enriched R2: 3.988/0.02701 |
CHAT | 3.198 | 0.971 | 0.746 | - | 0.736 | - | 0.745 | Mlig455_068578 {REF} {Length: 3661} {TRANSSPLICED} {Pfam: Choline/Carnitine o-acyltransferase [PF00755.22, score=556.7]} {Human: ENSG00000070748, CHAT, choline O-acetyltransferase, [RH, Score=519, Expect=2e-177]} {Mouse: ENSMUSG00000021919, Chat, choline acetyltransferase, [RH, Score=520, Expect=7e-178]} {Dmel: FBgn0000303, ChAT, Choline acetyltransferase, [RH, Score=488, Expect=1e-164]} {Celegans: WBGene00000481, cha-1, Choline O-acetyltransferase, [RH, Score=363, Expect=2e-117]} {Smed: dd_Smed_v6_6208_0_1, dd_Smed_v6_6208_0_1, [RH, Score=601, Expect=0.0]} {RNA1509_36058} {RNA1310_3092, RNA1509_36058} {RNA1509_36058, RNA815_2435.1} |
27. | MligTC455_39663 | 257 | 5.36 | Mlig455_035826 | Neo: - Age: - Region-enriched R2: 2.079/0.03628 |
ERG | 3.195 | 0.704 | 0.752 | 0.965 | - | - | 0.774 | Mlig455_035826 {REF} {Length: 1844} {Pfam: Ets-domain [PF00178.24, score=118.3]} {Human: ENSG00000157554, ERG, ERG, ETS transcription factor, [RH, Score=206, Expect=1e-62]; ENSG00000151702, FLI1, Fli-1 proto-oncogene, ETS transcription factor, [RH, Score=200, Expect=1e-62]} {Mouse: ENSMUSG00000040732, Erg, ETS transcription factor, [RH, Score=204, Expect=2e-62]; ENSMUSG00000016087, Fli1, Friend leukemia integration 1, [RH, Score=200, Expect=2e-60]} {Dmel: FBgn0005658, Ets65A, Ets at 65A, [RH, Score=211, Expect=3e-67]} {Celegans: WBGene00020368, ast-1, Axon STeering defect, [RH, Score=185, Expect=5e-56]} {Smed: dd_Smed_v6_11113_0_1, dd_Smed_v6_11113_0_1, [RH, Score=237, Expect=2e-76]} {RNA1509_29423} {RNA1310_27275.1, RNA1509_29423} {RNA1509_29423, RNA815_13091} |
28. | MligTC455_14831 | 280 | 5.83 | Mlig455_067864 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.261/0.00352 |
SSUH2 | 2.81 | - | 0.863 | - | 0.971 | - | 0.976 | Mlig455_067864 {REF} {Length: 1575} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=184, Expect=6e-54]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=148, Expect=7e-41]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=118, Expect=1e-29]} {RNA1509_46058} {RNA1310_5028.1} {RNA815_5650} |
29. | MligTC455_44713 | 661 | 13.77 | Mlig455_048154 | Neo: - Age: logFC(26M/2M)=0.569 Region-specific R2: 3.883 Region-enriched R2: 3.422/0.00000 |
2.803 | 0.959 | 0.927 | - | - | - | 0.917 | Mlig455_048154 {REF} {Length: 1173} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
30. | MligTC455_14483 | 140 | 2.92 | Mlig455_028240 | Neo: - Age: - Region-enriched R2: 6.203/0.04837 |
2.798 | 0.937 | - | 0.976 | - | - | 0.885 | Mlig455_028240 {REF} {Length: 728} {RNA1310_111517} {RNA815_9716} | |
31. | MligTC455_51200 | 66 | 1.37 | Mlig455_057090 | Neo: - Age: - |
2.787 | 0.962 | 0.903 | - | - | 0.922 | - | Mlig455_057090 {REF} {Length: 988} {RNA1310_63663} {RNA815_36272} | |
32. | MligTC455_32164 | 149 | 3.11 | Mlig455_028109 | Neo: - Age: - |
2.767 | 0.950 | 0.848 | - | - | - | 0.969 | Mlig455_028109 {REF} {Length: 205} {NoTransDecoderORF} {RNA1310_31190} {RNA815_49804} | |
33. | MligTC455_32165 | 302 | 6.3 | Mlig455_028110, Mlig455_045231, Mlig455_069146 | Neo: - Age: - |
2.764 | 0.949 | 0.848 | - | - | - | 0.967 | Mlig455_028110 {REF} {Length: 668} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=31.4]; PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=19.9]} {Smed: dd_Smed_v6_7982_0_1, dd_Smed_v6_7982_0_1, [Score=69.7, Expect=4e-14]} {RNA1310_31139.2} {RNA815_42018} Mlig455_045231 {REF} {Length: 2983} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=46.7]} {Smed: dd_Smed_v6_7982_0_1, dd_Smed_v6_7982_0_1, [RH, Score=115, Expect=4e-29]} {RNA1509_55345} {RNA1310_31139.1} {RNA815_42018} Mlig455_069146 {REF} {Length: 1639} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=40.1]} {Smed: dd_Smed_v6_16515_0_1, dd_Smed_v6_16515_0_1, [RH, Score=99.0, Expect=7e-25]} {RNA1310_31190} {RNA815_42018} |
|
34. | MligTC455_21755 | 70 | 1.47 | Mlig455_021213 | Neo: - Age: - |
2.746 | 0.969 | 0.893 | - | - | - | 0.884 | Mlig455_021213 {REF} {Length: 4215} {Pfam: F5/8 type C domain [PF00754.27, score=55.5]} {RNA1509_2515} {RNA1310_33166} {RNA815_14716} | |
35. | MligTC455_38682 | 102 | 2.12 | Mlig455_039641 | Neo: - Age: - Region-enriched R2: 6.138/0.02363 |
SLC18A3 | 2.742 | 0.971 | 0.918 | - | - | - | 0.853 | Mlig455_039641 {REF} {Length: 3925} {Pfam: Major Facilitator Superfamily [PF07690.18, score=147.1]; Sugar (and other) transporter [PF00083.26, score=29.0]; LacY proton/sugar symporter [PF01306.21, score=20.2]} {Human: ENSG00000187714, SLC18A3, solute carrier family 18 member A3, [RH, Score=469, Expect=9e-161]} {Mouse: ENSMUSG00000100241, Slc18a3, solute carrier family 18 (vesicular monoamine), member 3, [RH, Score=469, Expect=1e-160]} {Dmel: FBgn0270928, VAChT, Vesicular acetylcholine transporter, [RH, Score=513, Expect=2e-177]} {Celegans: WBGene00006756, unc-17, Vesicular acetylcholine transporter unc-17, [RH, Score=486, Expect=2e-167]} {Smed: dd_Smed_v6_11630_0_1, dd_Smed_v6_11630_0_1, [RH, Score=563, Expect=0.0]} {RNA1310_28397} {RNA815_32284.1} |
36. | MligTC455_15949 | 37 | 0.76 | Mlig455_059880 | Neo: - Age: - |
2.741 | 0.970 | - | - | 0.913 | - | 0.858 | Mlig455_059880 {REF} {Length: 1226} {Pfam: Lectin C-type domain [PF00059.23, score=39.5]} {Dmel: FBgn0031373, CG15358, [Score=52.8, Expect=4e-08]} {RNA1310_120903} | |
37. | MligTC455_23543 | 79 | 1.65 | Mlig455_021851 | Neo: - Age: - Region-enriched R2: 5.153/0.00077 |
MAP3K19 | 2.714 | 0.856 | - | - | 0.900 | - | 0.958 | Mlig455_021851 {REF} {Length: 7454} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=226.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=217.3]; Ankyrin repeats (3 copies) [PF12796.9, score=113.8]; Ankyrin repeats (many copies) [PF13637.8, score=82.7]; Ankyrin repeats (many copies) [PF13857.8, score=77.3]; F5/8 type C domain [PF00754.27, score=56.3]; Ankyrin repeat [PF00023.32, score=55.9]; Ankyrin repeat [PF13606.8, score=49.9]; ABC1 atypical kinase-like domain [PF03109.18, score=28.7]} {Human: ENSG00000176601, MAP3K19, mitogen-activated protein kinase kinase kinase 19, [Score=159, Expect=2e-40]} {Mouse: ENSMUSG00000051590, Map3k19, mitogen-activated protein kinase kinase kinase 19, [Score=164, Expect=3e-42]} {Dmel: FBgn0266465, GckIII, Germinal centre kinase III, [Score=146, Expect=1e-35]} {Celegans: WBGene00001526, gck-1, Germinal center kinase 1, [Score=139, Expect=2e-33]} {Smed: dd_Smed_v6_10339_0_1, dd_Smed_v6_10339_0_1, [Score=153, Expect=2e-37]} {RNA1509_46581} {RNA1310_9191} {RNA815_12161} |
38. | MligTC455_54338 | 49 | 1.02 | Mlig455_056485 | Neo: - Age: Up-Down-Down |
PKDREJ | 2.714 | 0.972 | 0.844 | - | - | - | 0.898 | Mlig455_056485 {REF} {Length: 11174} {Pfam: Polycystin cation channel [PF08016.14, score=290.0]; REJ domain [PF02010.17, score=90.7]; PLAT/LH2 domain [PF01477.25, score=67.3]; PKD domain [PF00801.22, score=47.7]; Ion transport protein [PF00520.33, score=40.1]; PKD domain [PF18911.2, score=29.8]; GPCR proteolysis site, GPS, motif [PF01825.23, score=27.4]; WSC domain [PF01822.21, score=27.0]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=280, Expect=1e-74]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=307, Expect=8e-83]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=151, Expect=3e-36]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [RH, Score=302, Expect=1e-81]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [RH, Score=1844, Expect=0.0]} {RNA1509_16432} {RNA1310_1236} {RNA815_2411} |
39. | MligTC455_34524 | 155 | 3.22 | Mlig455_021291 | Neo: - Age: Down-Up-Down Region-specific R2: 4.905 Region-enriched R2: 4.200/0.01842 |
2.704 | 0.961 | 0.853 | - | - | - | 0.890 | Mlig455_021291 {REF} {Length: 1478} {NoTransDecoderORF} {RNA1509_56543} {RNA1310_26920, RNA1509_56543} {RNA1509_56543, RNA815_11718} | |
40. | MligTC455_14830 | 177 | 3.68 | Mlig455_066372 | Neo: - Age: - |
SSUH2 | 2.701 | - | 0.803 | - | 0.906 | - | 0.992 | Mlig455_066372 {REF} {Length: 1569} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=184, Expect=2e-53]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=148, Expect=1e-40]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=119, Expect=2e-29]} {RNA1509_46058} {RNA1310_5028.1, RNA1509_46058} {RNA1509_46058, RNA815_5650} |
41. | MligTC455_35945 | 130 | 2.71 | Mlig455_065474 | Neo: - Age: Up-Down-Up |
2.697 | - | 0.806 | 0.970 | - | - | 0.921 | Mlig455_065474 {REF} {Length: 1654} {RNA1310_22530} {RNA815_54411} | |
42. | MligTC455_29045 | 127 | 2.65 | Mlig455_056054 | Neo: - Age: - Region-enriched R2: 4.858/0.00652 |
FZD5 | 2.695 | 0.956 | 0.843 | - | - | - | 0.896 | Mlig455_056054 {REF} {Length: 3655} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=389.0]; Fz domain [PF01392.24, score=85.2]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [Score=554, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [Score=561, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [Score=516, Expect=5e-176]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=368, Expect=3e-120]} {Smed: dd_Smed_v6_16571_0_1, dd_Smed_v6_16571_0_1, [Score=522, Expect=7e-178]} {RNA1509_35313} {RNA1310_9623.1} {RNA815_2562.1} |
43. | MligTC455_39860 | 56 | 1.17 | Mlig455_046932 | Neo: - Age: - |
2.692 | 0.915 | - | 0.955 | - | - | 0.822 | Mlig455_046932 {REF} {Length: 920} {RNA1310_30968} {RNA815_45889} | |
44. | MligTC455_21182 | 238 | 4.96 | Mlig455_000068, Mlig455_063733 | Neo: - Age: Down-Up-Up Region-enriched R4: 5.301/0.04587 |
2.691 | 0.950 | 0.855 | - | - | - | 0.886 | Mlig455_000068 {REF} {Length: 468} {Pfam: Pancreatic hormone peptide [PF00159.20, score=23.7]} {RNA1310_81800.1} {RNA815_55075} Mlig455_063733 {REF} {Length: 531} {Pfam: Pancreatic hormone peptide [PF00159.20, score=20.7]} {RNA1310_81800.1} {RNA815_55075} |
|
45. | MligTC455_16873 | 645 | 13.43 | Mlig455_006290 | Neo: - Age: Down-Up-Up Region-enriched R2: 2.543/0.01560 |
2.688 | - | 0.860 | 0.957 | - | - | 0.871 | Mlig455_006290 {REF} {Length: 699} {RNA1310_48111} {RNA815_24753} | |
46. | MligTC455_29929 | 164 | 3.41 | Mlig455_030237, Mlig455_068015 | Neo: - Age: - Region-enriched R2: 4.901/0.00350 |
SIX6 | 2.688 | 0.953 | 0.842 | - | - | - | 0.893 | Mlig455_030237 {REF} {Length: 2545} {Pfam: Transcriptional regulator, SIX1, N-terminal SD domain [PF16878.7, score=152.1]; Homeodomain [PF00046.31, score=46.4]; Homeobox KN domain [PF05920.13, score=40.1]} {Human: ENSG00000184302, SIX6, SIX homeobox 6, [RH, Score=327, Expect=1e-109]; ENSG00000138083, SIX3, SIX homeobox 3, [RH, Score=325, Expect=8e-108]} {Mouse: ENSMUSG00000038805, Six3, sine oculis-related homeobox 3, [RH, Score=325, Expect=6e-108]; ENSMUSG00000021099, Six6, sine oculis-related homeobox 6, [RH, Score=323, Expect=2e-108]} {Dmel: FBgn0025360, Optix, [RH, Score=291, Expect=9e-93]} {Celegans: WBGene00000453, ceh-32, Homeobox protein ceh-32, [RH, Score=237, Expect=2e-72]} {Smed: dd_Smed_v6_11975_0_1, dd_Smed_v6_11975_0_1, [RH, Score=360, Expect=2e-119]} {RNA1509_39396} {RNA1310_25182.2} {RNA815_23127} Mlig455_068015 {REF} {Length: 2713} {Pfam: Transcriptional regulator, SIX1, N-terminal SD domain [PF16878.7, score=152.2]; Homeodomain [PF00046.31, score=46.4]; Homeobox KN domain [PF05920.13, score=40.1]} {Human: ENSG00000184302, SIX6, SIX homeobox 6, [RH, Score=327, Expect=1e-109]; ENSG00000138083, SIX3, SIX homeobox 3, [RH, Score=325, Expect=7e-108]} {Mouse: ENSMUSG00000038805, Six3, sine oculis-related homeobox 3, [RH, Score=325, Expect=5e-108]; ENSMUSG00000021099, Six6, sine oculis-related homeobox 6, [RH, Score=323, Expect=2e-108]} {Dmel: FBgn0025360, Optix, [RH, Score=291, Expect=1e-92]} {Celegans: WBGene00000453, ceh-32, Homeobox protein ceh-32, [RH, Score=237, Expect=1e-72]} {Smed: dd_Smed_v6_11975_0_1, dd_Smed_v6_11975_0_1, [RH, Score=360, Expect=1e-119]} {RNA1509_39396} {RNA1310_25182.2} {RNA815_23127} |
47. | MligTC455_19249 | 90 | 1.86 | Mlig455_054092 | Neo: - Age: Down-Up-Up Region-enriched R2: 7.298/0.00139 |
2.681 | 0.972 | 0.750 | - | - | - | 0.959 | Mlig455_054092 {REF} {Length: 667} {TRANSSPLICED} {RNA1509_57448} {RNA1310_51394, RNA1509_57448} {RNA1509_57448, RNA815_26076} | |
48. | MligTC455_41077 | 483 | 10.07 | Mlig455_031143, Mlig455_031151 | Neo: - |
SLC8A3 | 2.663 | - | 0.853 | 0.973 | - | - | 0.837 | Mlig455_031143 {REF} {Length: 4359} {Pfam: Sodium/calcium exchanger protein [PF01699.26, score=180.5]; Calx-beta domain [PF03160.16, score=179.5]; C-terminal extension of sodium/calcium exchanger domain [PF16494.7, score=92.3]} {Human: ENSG00000100678, SLC8A3, solute carrier family 8 member A3, [RH, Score=952, Expect=0.0]; ENSG00000183023, SLC8A1, solute carrier family 8 member A1, [RH, Score=932, Expect=0.0]} {Mouse: ENSMUSG00000079055, Slc8a3, solute carrier family 8 (sodium/calcium exchanger), member 3, [RH, Score=945, Expect=0.0]; ENSMUSG00000054640, Slc8a1, solute carrier family 8 (sodium/calcium exchanger), member 1, [RH, Score=936, Expect=0.0]; ENSMUSG00000030376, Slc8a2, solute carrier family 8 (sodium/calcium exchanger), member 2, [RH, Score=917, Expect=0.0]} {Dmel: FBgn0013995, Calx, Na/Ca-exchange protein, [RH, Score=829, Expect=0.0]} {Celegans: WBGene00003567, ncx-2, Na/Ca eXchangers, [RH, Score=878, Expect=0.0]} {Smed: dd_Smed_v6_3303_0_1, dd_Smed_v6_3303_0_1, [RH, Score=997, Expect=0.0]} {RNA1509_12866} {RNA1310_2685.1} {RNA815_13452} Mlig455_031151 {REF} {Length: 5266} {Pfam: Sodium/calcium exchanger protein [PF01699.26, score=179.9]; Calx-beta domain [PF03160.16, score=164.6]; C-terminal extension of sodium/calcium exchanger domain [PF16494.7, score=91.7]} {Human: ENSG00000100678, SLC8A3, solute carrier family 8 member A3, [Score=523, Expect=1e-169]; ENSG00000183023, SLC8A1, solute carrier family 8 member A1, [Score=498, Expect=7e-160]} {Mouse: ENSMUSG00000079055, Slc8a3, solute carrier family 8 (sodium/calcium exchanger), member 3, [Score=520, Expect=3e-168]; ENSMUSG00000054640, Slc8a1, solute carrier family 8 (sodium/calcium exchanger), member 1, [Score=503, Expect=7e-162]} {Dmel: FBgn0013995, Calx, Na/Ca-exchange protein, [Score=490, Expect=2e-160]} {Celegans: WBGene00003567, ncx-2, Na/Ca eXchangers, [Score=492, Expect=5e-158]} {Smed: dd_Smed_v6_3303_0_1, dd_Smed_v6_3303_0_1, [Score=549, Expect=4e-180]} {RNA1509_12866} {RNA1310_2685.2} {RNA815_13452} |
49. | MligTC455_18787 | 963 | 20.06 | Mlig455_014022 | Neo: - Age: - Region-enriched R2: 1.334/0.03482 |
STRC | 2.658 | - | - | 0.970 | 0.755 | - | 0.933 | Mlig455_014022 {REF} {Length: 5754} {Human: ENSG00000242866, STRC, stereocilin, [RH, Score=76.3, Expect=4e-13]} {Mouse: ENSMUSG00000033498, Strc, stereocilin, [RH, Score=80.9, Expect=1e-14]} {RNA1509_4378} {RNA1310_1493.1, RNA1509_4378} {RNA1509_4378, RNA815_804} |
50. | MligTC455_33039 | 312 | 6.51 | Mlig455_032494 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.545/0.00267 |
PKDREJ | 2.656 | 0.972 | 0.818 | - | - | - | 0.866 | Mlig455_032494 {REF} {Length: 11952} {Pfam: Polycystin cation channel [PF08016.14, score=289.9]; REJ domain [PF02010.17, score=90.4]; PLAT/LH2 domain [PF01477.25, score=68.4]; PKD domain [PF00801.22, score=57.9]; PKD domain [PF18911.2, score=36.7]; Ion transport protein [PF00520.33, score=36.3]; GPCR proteolysis site, GPS, motif [PF01825.23, score=30.0]; WSC domain [PF01822.21, score=23.3]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=267, Expect=1e-70]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=292, Expect=3e-78]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=136, Expect=2e-31]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [RH, Score=297, Expect=4e-80]} {Smed: dd_Smed_v6_15525_0_1, dd_Smed_v6_15525_0_1, [Score=1504, Expect=0.0]} {RNA1509_3444} {RNA1310_89} {RNA815_1814} |
51. | MligTC455_35019 | 168 | 3.49 | Mlig455_046994 | Neo: - Age: - |
ASIC4 | 2.652 | 0.957 | - | - | - | 0.781 | 0.914 | Mlig455_046994 {REF} {Length: 4001} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=101.4]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=76.3, Expect=1e-13]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=76.3, Expect=8e-14]; ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=72.8, Expect=8e-13]} {Smed: dd_Smed_v6_15233_0_1, dd_Smed_v6_15233_0_1, [RH, Score=103, Expect=1e-22]} {RNA1509_33816} {RNA1310_3176, RNA1509_33816} {RNA1509_33816, RNA815_12439} |
52. | MligTC455_49825 | 543 | 11.31 | Mlig455_069114 | Neo: - Age: Down-Up-Up Region-specific R2: 4.806 Region-enriched R2: 3.936/0.00000 |
2.65 | - | 0.783 | 0.951 | - | - | 0.916 | Mlig455_069114 {REF} {Length: 828} {Celegans: WBGene00003748, nlp-10, Neuropeptide-Like Protein, [Score=40.0, Expect=9e-06]} {RNA1509_26665} {RNA1310_48731, RNA1509_26665} {RNA1509_26665, RNA815_24488} | |
53. | MligTC455_34369 | 112 | 2.34 | Mlig455_015308, Mlig455_015354, Mlig455_036248, Mlig455_068737, Mlig455_070110 | Neo: - Age: Up-Down-Up Region-enriched R2: 5.462/0.00546 |
2.648 | 0.979 | 0.855 | - | - | - | 0.814 | Mlig455_015308 {REF} {Length: 1459} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.9]} {RNA1310_34740} {RNA815_15663} Mlig455_015354 {REF} {Length: 1446} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=66.3]; Sialidase, N-terminal domain [PF02973.18, score=18.5]} {RNA1310_34740} {RNA815_15663} Mlig455_036248 {REF} {Length: 2111} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=120.9]; Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=28.5]; PAN domain [PF00024.28, score=19.9]} {RNA1509_45496} {RNA1310_2539.1} {RNA815_252.1} Mlig455_068737 {REF} {Length: 1096} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=68.3]; Sialidase, N-terminal domain [PF02973.18, score=19.9]} {RNA1310_34740} {RNA815_37905} Mlig455_070110 {REF} {Length: 1340} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=109.6]} {RNA1509_32599} {RNA1310_1659} {RNA815_252.1} |
|
54. | MligTC455_52656 | 121 | 2.51 | Mlig455_062381, Mlig455_062408 | Neo: - Age: Down-Up-Down |
2.646 | 0.960 | 0.759 | - | - | - | 0.927 | Mlig455_062381 {REF} {Length: 2245} {RNA1310_26272} {RNA815_22826} Mlig455_062408 {REF} {Length: 2277} {RNA1310_26272} {RNA815_37592} |
|
55. | MligTC455_46341 | 243 | 5.06 | Mlig455_052880, Mlig455_052884 | Neo: - Age: - |
2.64 | 0.733 | - | 0.953 | - | - | 0.954 | Mlig455_052880 {REF} {Length: 1228} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=28.6]; Dpy-30 motif [PF05186.15, score=22.0]; Ankyrin repeats (many copies) [PF13637.8, score=20.9]} {Smed: dd_Smed_v6_29956_0_1, dd_Smed_v6_29956_0_1, [Score=60.5, Expect=6e-10]} {RNA1509_39973} {RNA1310_21889} {RNA815_13094} Mlig455_052884 {REF} {Length: 1926} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=39.4]; Ankyrin repeats (many copies) [PF13637.8, score=27.7]; Ankyrin repeats (many copies) [PF13857.8, score=24.6]; Dpy-30 motif [PF05186.15, score=21.6]} {Smed: dd_Smed_v6_29956_0_1, dd_Smed_v6_29956_0_1, [Score=72.8, Expect=1e-13]} {RNA1509_39973} {RNA1310_21889, RNA1509_39973} {RNA1509_39973, RNA815_13094} |
|
56. | MligTC455_54203 | 182 | 3.79 | Mlig455_061249 | Neo: - Age: - |
MYH7 | 2.639 | - | - | 0.892 | 0.794 | - | 0.953 | Mlig455_061249 {REF} {Length: 1536} {Pfam: Myosin tail [PF01576.21, score=90.6]} {Human: ENSG00000092054, MYH7, myosin heavy chain 7, [Score=200, Expect=8e-57]; ENSG00000197616, MYH6, myosin heavy chain 6, [Score=198, Expect=4e-56]; ENSG00000264424, MYH4, myosin heavy chain 4, [Score=191, Expect=2e-53]; ENSG00000125414, MYH2, myosin heavy chain 2, [Score=190, Expect=4e-53]} {Mouse: ENSMUSG00000053093, Myh7, myosin, heavy polypeptide 7, cardiac muscle, beta, [Score=201, Expect=4e-57]; ENSMUSG00000040752, Myh6, myosin, heavy polypeptide 6, cardiac muscle, alpha, [Score=194, Expect=8e-55]; ENSMUSG00000057003, Myh4, myosin, heavy polypeptide 4, skeletal muscle, [Score=192, Expect=3e-54]; ENSMUSG00000056328, Myh1, myosin, heavy polypeptide 1, skeletal muscle, adult, [Score=191, Expect=1e-53]} {Dmel: FBgn0264695, Mhc, Myosin heavy chain, [Score=282, Expect=2e-85]} {Celegans: WBGene00003515, myo-3, Myosin-3, [Score=241, Expect=2e-71]} {Smed: dd_Smed_v6_432_0_1, dd_Smed_v6_432_0_1, [Score=285, Expect=9e-87]} {RNA1509_55838} {RNA1310_1388} {RNA815_21073} |
57. | MligTC455_47808 | 151 | 3.15 | Mlig455_066806 | Neo: - Age: - |
STAC2 | 2.637 | 0.848 | - | 0.982 | - | - | 0.807 | Mlig455_066806 {REF} {Length: 4661} {Pfam: SH3 domain [PF00018.30, score=41.7]; Variant SH3 domain [PF14604.8, score=35.5]} {Human: ENSG00000141750, STAC2, SH3 and cysteine rich domain 2, [RH, Score=72.8, Expect=1e-12]} {Mouse: ENSMUSG00000017400, Stac2, SH3 and cysteine rich domain 2, [RH, Score=72.0, Expect=2e-12]} {Dmel: FBgn0263980, CG43729, [RH, Score=149, Expect=5e-36]} {Celegans: WBGene00006791, unc-57, Endophilin-A homolog, [Score=53.9, Expect=2e-08]} {Smed: dd_Smed_v6_14652_0_1, dd_Smed_v6_14652_0_1, [Score=172, Expect=1e-43]} {RNA1509_54523} {RNA1310_1618} {RNA815_6997} |
58. | MligTC455_39481 | 461 | 9.6 | Mlig455_056703, Mlig455_060318 | Neo: - Age: Down-Up-Up Region-specific R2: 4.222 |
ANGPTL1 | 2.631 | 0.960 | 0.780 | - | - | - | 0.891 | Mlig455_056703 {REF} {Length: 1114} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=79.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=89.4, Expect=1e-19]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=85.1, Expect=3e-18]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=91.3, Expect=2e-20]} {Dmel: FBgn0033312, CG8642, [Score=82.4, Expect=1e-17]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=76.3, Expect=1e-15]} {RNA1310_31288} {RNA815_20497.1} Mlig455_060318 {REF} {Length: 1175} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=112.7]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=106, Expect=2e-25]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=6e-26]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=109, Expect=1e-26]} {Dmel: FBgn0034160, CG5550, [Score=96.3, Expect=2e-23]} {Celegans: WBGene00016769, C49C8.5, [Score=47.0, Expect=9e-06]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=88.2, Expect=2e-19]} {RNA1310_31288} {RNA815_20497.1} |
59. | MligTC455_43324 | 71 | 1.47 | Mlig455_041984 | Neo: - Age: - Region-enriched R2: 6.623/0.00573 |
2.629 | - | 0.857 | - | - | 0.821 | 0.951 | Mlig455_041984 {REF} {Length: 388} {NoTransDecoderORF} {RNA1509_49821} {RNA1310_52560.2} {RNA815_59873} | |
60. | MligTC455_19328 | 99 | 2.06 | Mlig455_062531 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.972/0.00232 |
2.629 | 0.957 | 0.835 | - | - | - | 0.837 | Mlig455_062531 {REF} {Length: 1929} {NoTransDecoderORF} {RNA1509_36058} {RNA1310_3092} {RNA815_16673} | |
61. | MligTC455_44712 | 665 | 13.86 | Mlig455_017186 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.471 Region-specific R2: 4.141 Region-enriched R2: 3.536/0.00000 |
2.602 | 0.730 | 0.896 | - | - | - | 0.976 | Mlig455_017186 {REF} {Length: 1018} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
62. | MligTC455_53339 | 361 | 7.52 | Mlig455_044792, Mlig455_044816, Mlig455_055565 | Neo: - Age: - Region-enriched R2: 2.402/0.04439 |
DMBT1 | 2.6 | 0.915 | 0.709 | - | - | - | 0.976 | Mlig455_044792 {REF} {Length: 2555} {Pfam: Zona pellucida-like domain [PF00100.25, score=90.4]; Scavenger receptor cysteine-rich domain [PF00530.20, score=77.7]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=67.0, Expect=8e-11]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=58.2, Expect=3e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=73.9, Expect=9e-14]} {RNA1509_36885} {RNA1310_10008} {RNA815_6134} Mlig455_044816 {REF} {Length: 2732} {Pfam: Zona pellucida-like domain [PF00100.25, score=89.0]; Scavenger receptor cysteine-rich domain [PF00530.20, score=78.1]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=67.0, Expect=9e-11]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=56.6, Expect=8e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=73.6, Expect=1e-13]} {RNA1509_36885} {RNA1310_10008, RNA1509_36885} {RNA1509_36885, RNA815_6134} Mlig455_055565 {REF} {Length: 2284} {Pfam: Scavenger receptor cysteine-rich domain [PF00530.20, score=79.3]; Zona pellucida-like domain [PF00100.25, score=35.8]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=65.5, Expect=1e-10]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=56.6, Expect=4e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=55.1, Expect=4e-08]} {RNA1509_36885} {RNA1310_10008} {RNA815_6134} |
63. | MligTC455_47704 | 106 | 2.21 | Mlig455_032247 | Neo: - |
WSCD2 | 2.597 | - | 0.725 | 0.921 | - | - | 0.951 | Mlig455_032247 {REF} {Length: 2305} {Pfam: WSC domain [PF01822.21, score=58.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=54.7, Expect=1e-07]; ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.8, Expect=5e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.6, Expect=3e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.9, Expect=1e-10]} {RNA1509_59284} {RNA1310_13567} {RNA815_27780} |
64. | MligTC455_50172 | 243 | 5.05 | Mlig455_067182 | Neo: - Age: Down-Up-Up Region-specific R2: 6.036 Region-enriched R2: 6.524/0.00000 |
2.597 | 0.779 | 0.836 | - | - | - | 0.982 | Mlig455_067182 {REF} {Length: 638} {Pfam: Pancreatic hormone peptide [PF00159.20, score=47.5]} {RNA1509_60030} {RNA1310_56761, RNA1509_60030} {RNA1509_60030, RNA815_31877.1} | |
65. | MligTC455_16908 | 161 | 3.35 | Mlig455_046916 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.397 Region-enriched R2: 2.938/0.02849 |
SLC17A6 | 2.585 | 0.961 | 0.724 | - | - | - | 0.900 | Mlig455_046916 {REF} {Length: 3198} {Pfam: Major Facilitator Superfamily [PF07690.18, score=172.0]; Uncharacterised MFS-type transporter YbfB [PF06779.16, score=19.6]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=548, Expect=0.0]; ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=542, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=536, Expect=0.0]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=551, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=547, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=543, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=482, Expect=6e-163]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=479, Expect=7e-163]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=591, Expect=0.0]} {RNA1509_38152} {RNA1310_23072, RNA1509_38152} {RNA1509_38152, RNA815_14894} |
66. | MligTC455_44328 | 858 | 17.88 | Mlig455_026172 | Neo: - Age: Down-Up-Up Region-specific R2: 4.714 Region-enriched R2: 4.385/0.00000 |
2.581 | 0.798 | 0.816 | - | - | - | 0.967 | Mlig455_026172 {REF} {Length: 661} {RNA1509_32102, RNA1509_34635} {RNA1310_60068, RNA1509_32102, RNA1509_34635} {RNA1509_32102, RNA1509_34635, RNA815_37486} | |
67. | MligTC455_02516 | 97 | 2.01 | Mlig455_055457 | Neo: - Age: - |
2.577 | - | 0.759 | - | 0.853 | - | 0.965 | Mlig455_055457 {REF} {Length: 4031} {Pfam: Glycine-rich domain-containing protein-like [PF07173.14, score=151.1]} {Celegans: WBGene00017980, F32B5.7, [RH, Score=268, Expect=8e-78]} {Smed: dd_Smed_v6_5132_0_1, dd_Smed_v6_5132_0_1, [RH, Score=383, Expect=7e-121]} {RNA1509_5401} {RNA1310_7934.1, RNA1509_5401} {RNA1509_5401, RNA815_2330} | |
68. | MligTC455_40040 | 365 | 7.61 | Mlig455_008332 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.784 Region-specific R2: 6.834 Region-enriched R2: 5.705/0.00005 |
2.57 | 0.950 | - | 0.836 | - | - | 0.784 | Mlig455_008332 {REF} {Length: 707} {RNA1509_39735} {RNA1310_73916, RNA1509_39735} {RNA1509_39735, RNA815_42730.2} | |
69. | MligTC455_26492 | 60 | 1.25 | Mlig455_018508 | Neo: - Age: - |
2.543 | - | 0.773 | 0.802 | - | - | 0.968 | Mlig455_018508 {REF} {Length: 1700} {Pfam: Helix-turn-helix domain [PF13518.8, score=23.2]} {RNA1509_38400} {RNA1310_5895.2} {RNA815_1641.1} | |
70. | MligTC455_38775 | 266 | 5.54 | Mlig455_066758, Mlig455_069705 | Neo: - Age: - Region-specific R2: 6.147 Region-enriched R2: 5.505/0.02411 |
WNT6 | 2.53 | - | 0.820 | - | 0.728 | - | 0.982 | Mlig455_066758 {REF} {Length: 2739} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=9e-15]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=6e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=74.3, Expect=9e-14]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.9, Expect=4e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=71.2, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.2} {RNA815_8552} Mlig455_069705 {REF} {Length: 2713} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=1e-14]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=7e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=73.9, Expect=1e-13]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.6, Expect=6e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=70.9, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.1, RNA1509_23528} {RNA1509_23528, RNA815_8552} |
71. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 2.528 | 0.766 | 0.805 | - | - | - | 0.957 | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
72. | MligTC455_28695 | 95 | 1.98 | Mlig455_033490 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.072/0.04773 |
PLCH2 | 2.52 | 0.964 | - | - | - | 0.780 | 0.776 | Mlig455_033490 {REF} {Length: 13918} {tRNA: Undet(NNN),pseudo, score=20.5} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=199.7]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=104.2]; RasGEF domain [PF00617.21, score=53.7]; Ras association (RalGDS/AF-6) domain [PF00788.25, score=44.8]; FERM central domain [PF00373.20, score=29.5]; C2 domain [PF00168.32, score=27.4]; Ankyrin repeat [PF00023.32, score=22.4]; Ankyrin repeats (3 copies) [PF12796.9, score=21.4]} {Human: ENSG00000276429, PLCH2, phospholipase C eta 2, [Score=325, Expect=2e-89]; ENSG00000149527, PLCH2, phospholipase C eta 2, [Score=325, Expect=2e-89]} {Mouse: ENSMUSG00000024998, Plce1, phospholipase C, epsilon 1, [RH, Score=281, Expect=4e-75]} {Dmel: FBgn0003416, sl, small wing, [Score=167, Expect=1e-40]} {Celegans: WBGene00004036, plc-1, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1, [Score=248, Expect=3e-65]} {Smed: dd_Smed_v6_9716_1_1, dd_Smed_v6_9716_1_1, [RH, Score=739, Expect=0.0]} {RNA1509_26054} {RNA1310_1143.2, RNA1509_26054} {RNA1509_26054, RNA815_10233} |
73. | MligTC455_54019 | 59 | 1.23 | Mlig455_050979 | Neo: - Age: logFC(26M/2M)=0.902 |
DEGS2 | 2.501 | - | 0.728 | - | 0.811 | - | 0.962 | Mlig455_050979 {REF} {Length: 2343} {Pfam: Fatty acid desaturase [PF00487.26, score=84.5]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=59.9]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=332, Expect=1e-111]} {Mouse: ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=320, Expect=3e-107]; ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=304, Expect=8e-101]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=354, Expect=1e-120]} {Celegans: WBGene00013197, ttm-5, Putative sphingolipid delta(4)-desaturase/C4-monooxygenase, [Score=325, Expect=1e-108]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=422, Expect=6e-147]} {RNA1509_11966, RNA1509_33417, RNA1509_59878} {RNA1310_11518, RNA1509_11966, RNA1509_33417, RNA1509_59878} {RNA1509_11966, RNA1509_33417, RNA1509_59878, RNA815_6718} |
74. | MligTC455_53414 | 331 | 6.9 | Mlig455_053442 | Neo: - Age: - Region-specific R2: 4.308 Region-enriched R2: 3.374/0.00040 |
RP1 | 2.486 | - | 0.771 | - | 0.747 | - | 0.968 | Mlig455_053442 {REF} {Length: 1156} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_21828} {RNA1310_33070.1} {RNA815_13802.1} |
75. | MligTC455_53415 | 319 | 6.64 | Mlig455_053444 | Neo: - Age: Up-Down-Down Region-specific R2: 4.862 Region-enriched R2: 4.179/0.00011 |
RP1 | 2.482 | - | 0.771 | - | 0.742 | - | 0.969 | Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469} |
76. | MligTC455_45020 | 386 | 8.05 | Mlig455_012422 | Neo: - Age: - Region-enriched R2: 4.067/0.00066 |
AVP | 2.441 | 0.746 | 0.741 | - | - | - | 0.954 | Mlig455_012422 {REF} {Length: 1252} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.0]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=50.4, Expect=4e-08]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=52.0, Expect=7e-09]} {RNA1509_50574} {RNA1310_26737, RNA1509_50574} {RNA1509_50574, RNA815_23813} |
77. | MligTC455_21033 | 1129 | 23.52 | Mlig455_010672 | Neo: - Age: logFC(26M/2M)=0.356 Region-specific R2: 3.326 Region-enriched R2: 2.739/0.00000 Regeneration-downregulated R2: -1.967 Regeneration-depleted R2: -1.967 |
2.44 | 0.956 | 0.752 | - | - | - | 0.732 | Mlig455_010672 {REF} {Length: 829} {RNA1509_30331, RNA1509_45731} {RNA1310_60944, RNA1509_30331, RNA1509_45731} {RNA1509_30331, RNA1509_45731, RNA815_27381.1} | |
78. | MligTC455_53413 | 249 | 5.2 | Mlig455_035022 | Neo: - Age: - Region-specific R2: 4.451 Region-enriched R2: 3.023/0.00460 |
RP1 | 2.428 | - | 0.743 | - | 0.705 | - | 0.980 | Mlig455_035022 {REF} {Length: 5065} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_57003} {RNA1310_2710} {RNA815_13802.1} |
79. | MligTC455_15598 | 45 | 0.94 | Mlig455_021461 | Neo: - Age: Down-Up-Up |
2.394 | 0.725 | - | - | 0.715 | - | 0.954 | Mlig455_021461 {REF} {Length: 2020} {RNA1310_35982.1} {RNA815_27626} | |
80. | MligTC455_40657 | 90 | 1.87 | Mlig455_040779 | Neo: - Age: - |
CLIP2 | 2.386 | 0.966 | 0.714 | - | 0.706 | - | - | Mlig455_040779 {REF} {Length: 2164} {Pfam: CAP-Gly domain [PF01302.27, score=60.7]} {Human: ENSG00000106665, CLIP2, CAP-Gly domain containing linker protein 2, [Score=61.6, Expect=2e-09]} {Mouse: ENSMUSG00000063146, Clip2, CAP-GLY domain containing linker protein 2, [Score=62.0, Expect=1e-09]} {Dmel: FBgn0036882, CG9279, [Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_12985_0_1, dd_Smed_v6_12985_0_1, [Score=56.2, Expect=2e-08]} {RNA1310_20676} {RNA815_40746} |
81. | MligTC455_44177 | 70 | 1.46 | Mlig455_022828, Mlig455_022920 | Neo: - Age: - |
TNKS | 2.385 | - | - | - | 0.710 | 0.713 | 0.962 | Mlig455_022828 {REF} {Length: 1654} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=58.3]; Ankyrin repeats (many copies) [PF13637.8, score=51.4]; Ankyrin repeats (many copies) [PF13857.8, score=43.5]; Ankyrin repeat [PF00023.32, score=38.9]; Ankyrin repeat [PF13606.8, score=35.6]} {Dmel: FBgn0039955, CG41099, [Score=56.6, Expect=5e-08]} {Celegans: WBGene00001411, fem-1, Sex-determining protein fem-1, [Score=53.1, Expect=4e-07]} {Smed: dd_Smed_v6_11252_0_1, dd_Smed_v6_11252_0_1, [Score=50.8, Expect=1e-06]} {RNA1509_39040} {RNA1310_886.1} {RNA815_14632} Mlig455_022920 {REF} {Length: 1424} {Pfam: Ankyrin repeats (many copies) [PF13637.8, score=65.4]; Ankyrin repeats (3 copies) [PF12796.9, score=61.1]; Ankyrin repeats (many copies) [PF13857.8, score=57.9]; Ankyrin repeat [PF13606.8, score=50.1]; Ankyrin repeat [PF00023.32, score=49.7]} {Human: ENSG00000173273, TNKS, tankyrase, [Score=56.2, Expect=9e-08]; ENSG00000236759, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000238134, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000285372, AC270292.3, tankyrase, [Score=55.5, Expect=2e-07]; ENSG00000232045, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000206376, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000227333, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000204371, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000224143, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=54.3, Expect=3e-07]; ENSG00000029534, ANK1, ankyrin 1, [Score=53.5, Expect=8e-07]} {Mouse: ENSMUSG00000096265, 4930467E23Rik, RIKEN cDNA 4930467E23 gene, [Score=56.6, Expect=3e-08]; ENSMUSG00000074449, Gm15319, predicted gene 15319, [Score=56.6, Expect=3e-08]; ENSMUSG00000095294, Gm21119, predicted gene, 21119, [Score=56.2, Expect=3e-08]; ENSMUSG00000031529, Tnks, tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase, [Score=56.2, Expect=6e-08]; ENSMUSG00000013787, Ehmt2, euchromatic histone lysine N-methyltransferase 2, [Score=55.1, Expect=2e-07]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=55.1, Expect=2e-07]; ENSMUSG00000110591, Gm31371, predicted gene, 31371, [Score=54.3, Expect=8e-08]; ENSMUSG00000107280, Gm9495, predicted gene 9495, [Score=53.9, Expect=2e-07]; ENSMUSG00000106824, Gm7697, predicted gene 7697, [Score=53.9, Expect=2e-07]} {Dmel: FBgn0040752, Prosap, [Score=58.5, Expect=1e-08]} {Celegans: WBGene00001411, fem-1, Sex-determining protein fem-1, [Score=51.6, Expect=9e-07]} {Smed: dd_Smed_v6_2072_0_20, dd_Smed_v6_2072_0_20, [Score=59.3, Expect=3e-09]} {RNA1509_39040} {RNA1310_19494} {RNA815_14632} |
82. | MligTC455_44176 | 89 | 1.85 | Mlig455_022911 | Neo: - Age: - |
TNKS | 2.378 | - | - | - | 0.704 | 0.715 | 0.959 | Mlig455_022911 {REF} {Length: 1883} {Pfam: Ankyrin repeats (many copies) [PF13637.8, score=67.0]; Ankyrin repeats (3 copies) [PF12796.9, score=64.6]; Ankyrin repeats (many copies) [PF13857.8, score=59.2]; Ankyrin repeat [PF13606.8, score=50.9]; Ankyrin repeat [PF00023.32, score=50.1]} {Human: ENSG00000173273, TNKS, tankyrase, [Score=57.8, Expect=3e-08]; ENSG00000285372, AC270292.3, tankyrase, [Score=56.6, Expect=7e-08]; ENSG00000236759, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000238134, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000204371, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000206376, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000227333, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000232045, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000224143, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000029534, ANK1, ankyrin 1, [Score=55.5, Expect=2e-07]} {Mouse: ENSMUSG00000095294, Gm21119, predicted gene, 21119, [Score=57.8, Expect=1e-08]; ENSMUSG00000096265, 4930467E23Rik, RIKEN cDNA 4930467E23 gene, [Score=57.8, Expect=1e-08]; ENSMUSG00000031529, Tnks, tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase, [Score=57.8, Expect=2e-08]; ENSMUSG00000074449, Gm15319, predicted gene 15319, [Score=57.4, Expect=1e-08]; ENSMUSG00000013787, Ehmt2, euchromatic histone lysine N-methyltransferase 2, [Score=55.8, Expect=9e-08]; ENSMUSG00000063932, Poteg, POTE ankyrin domain family, member G, [Score=55.5, Expect=8e-08]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=55.5, Expect=1e-07]; ENSMUSG00000110591, Gm31371, predicted gene, 31371, [Score=55.5, Expect=4e-08]; ENSMUSG00000106824, Gm7697, predicted gene 7697, [Score=55.1, Expect=8e-08]; ENSMUSG00000107280, Gm9495, predicted gene 9495, [Score=55.1, Expect=8e-08]} {Dmel: FBgn0040752, Prosap, [Score=58.9, Expect=6e-09]} {Celegans: WBGene00001411, fem-1, Sex-determining protein fem-1, [Score=53.5, Expect=2e-07]} {Smed: dd_Smed_v6_2072_0_22, dd_Smed_v6_2072_0_22, [Score=62.0, Expect=4e-10]} {RNA1509_39040} {RNA1310_19494} {RNA815_14632} |
83. | MligTC455_52164 | 49 | 1.01 | Mlig455_019248 | Neo: - Age: Down-Up-Up Region-enriched R1: 12.972/0.02781 |
1.929 | 0.957 | - | - | - | - | 0.972 | Mlig455_019248 {REF} {Length: 923} {Celegans: WBGene00015646, mlt-10, [Score=98.2, Expect=4e-23]} {RNA1509_24360} {RNA1310_75398} {RNA815_40298} | |
84. | MligTC455_35895 | 102 | 2.12 | Mlig455_063971 | Neo: - Age: - |
RYK | 1.922 | 0.959 | - | - | - | - | 0.963 | Mlig455_063971 {REF} {Length: 3496} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=209.4]; WIF domain [PF02019.20, score=109.7]; Protein kinase domain [PF00069.27, score=79.1]} {Human: ENSG00000163785, RYK, receptor-like tyrosine kinase, [Score=202, Expect=1e-55]} {Mouse: ENSMUSG00000032547, Ryk, receptor-like tyrosine kinase, [RH, Score=202, Expect=2e-55]} {Dmel: FBgn0015380, drl, derailed, [RH, Score=239, Expect=4e-69]} {Celegans: WBGene00003007, lin-18, Inactive tyrosine-protein kinase RYK, [Score=179, Expect=6e-48]} {Smed: dd_Smed_v6_12594_0_2, dd_Smed_v6_12594_0_2, [Score=201, Expect=3e-55]} {RNA1509_58811} {RNA1310_6671.2} {RNA815_41921} |
85. | MligTC455_21502 | 36 | 0.75 | Mlig455_018529 | Neo: - Age: - Region-enriched R2: 5.380/0.01311 |
1.913 | 0.950 | - | - | - | - | 0.963 | Mlig455_018529 {REF} {Length: 1004} {Pfam: Fas apoptotic inhibitory molecule (FAIM1) [PF06905.15, score=43.7]} {Mouse: ENSMUSG00000032463, Faim, Fas apoptotic inhibitory molecule, [Score=54.7, Expect=2e-09]} {Smed: dd_Smed_v6_4798_0_1, dd_Smed_v6_4798_0_1, [RH, Score=75.1, Expect=7e-18]} {RNA1310_42034} {RNA815_19884} | |
86. | MligTC455_29915 | 50 | 1.04 | Mlig455_027934 | Neo: - Age: Down-Up-Up Region-enriched R2: 6.881/0.04464 |
ANGPTL1 | 1.911 | 0.967 | - | - | - | - | 0.944 | Mlig455_027934 {REF} {Length: 2265} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=43.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=48.9, Expect=9e-06]} {Dmel: FBgn0031804, CG9500, [Score=53.1, Expect=9e-08]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=49.7, Expect=1e-06]} {RNA1509_53291} {RNA1310_38229.1} {RNA815_10579.1} |
87. | MligTC455_36194 | 30 | 0.61 | Mlig455_064360, Mlig455_064382 | Neo: - Age: - |
B3GNT4 | 1.9 | - | 0.956 | - | - | - | 0.944 | Mlig455_064360 {REF} {Length: 3119} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.0, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=3e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.2, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=91.7, Expect=1e-19]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} Mlig455_064382 {REF} {Length: 3084} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.4, Expect=2e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=92.0, Expect=9e-20]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} |
88. | MligTC455_17021 | 49 | 1.02 | Mlig455_030263 | Neo: - Age: - |
1.894 | 0.955 | - | - | - | - | 0.939 | Mlig455_030263 {REF} {Length: 566} {TRANSSPLICED} {Pfam: Galactosyltransferase [PF01762.23, score=23.7]} {Dmel: FBgn0000221, brn, brainiac, [Score=45.8, Expect=1e-06]} {RNA1310_35735} {RNA815_59866} | |
89. | MligTC455_16875 | 42 | 0.88 | Mlig455_028243 | Neo: - Age: Up-Down-Down |
KCNK16 | 1.889 | 0.932 | - | - | - | - | 0.957 | Mlig455_028243 {REF} {Length: 2676} {Pfam: Ion channel [PF07885.18, score=116.8]; Ion transport protein [PF00520.33, score=28.8]; Protein of unknown function (DUF3112) [PF11309.10, score=19.5]} {Human: ENSG00000095981, KCNK16, potassium two pore domain channel subfamily K member 16, [Score=97.8, Expect=5e-22]; ENSG00000186795, KCNK18, potassium two pore domain channel subfamily K member 18, [Score=97.4, Expect=2e-21]; ENSG00000100433, KCNK10, potassium two pore domain channel subfamily K member 10, [Score=94.4, Expect=6e-20]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=102, Expect=4e-23]; ENSMUSG00000023387, Kcnk16, potassium channel, subfamily K, member 16, [Score=98.2, Expect=2e-22]} {Dmel: FBgn0033257, sand, sandman, [Score=150, Expect=2e-40]} {Celegans: WBGene00010784, twk-48, TWiK family of potassium channels, [Score=162, Expect=5e-45]} {Smed: dd_Smed_v6_17586_0_1, dd_Smed_v6_17586_0_1, [Score=340, Expect=2e-113]} {RNA1509_39975} {RNA1310_18301.1, RNA1509_39975} {RNA1509_39975, RNA815_12440} |
90. | MligTC455_32359 | 194 | 4.04 | Mlig455_054395, Mlig455_054418, Mlig455_070496 | Neo: - Age: - Region-enriched R2: 3.120/0.02401 |
STON2 | 1.888 | 0.980 | - | - | - | - | 0.908 | Mlig455_054395 {REF} {Length: 3807} {Pfam: Adaptor complexes medium subunit family [PF00928.23, score=152.1]} {Human: ENSG00000140022, STON2, stonin 2, [RH, Score=281, Expect=5e-80]} {Mouse: ENSMUSG00000020961, Ston2, stonin 2, [RH, Score=285, Expect=3e-82]} {Dmel: FBgn0016975, stnB, stoned B, [RH, Score=374, Expect=3e-112]} {Celegans: WBGene00006777, unc-41, Putative stoned B-like protein, [RH, Score=356, Expect=3e-104]} {Smed: dd_Smed_v6_6859_0_1, dd_Smed_v6_6859_0_1, [RH, Score=684, Expect=0.0]} {RNA1509_39423} {RNA1310_6760} {RNA815_11749} Mlig455_054418 {REF} {Length: 3915} {Pfam: Adaptor complexes medium subunit family [PF00928.23, score=153.1]} {Human: ENSG00000140022, STON2, stonin 2, [RH, Score=281, Expect=3e-80]} {Mouse: ENSMUSG00000020961, Ston2, stonin 2, [RH, Score=284, Expect=5e-82]} {Dmel: FBgn0016975, stnB, stoned B, [RH, Score=374, Expect=4e-112]} {Celegans: WBGene00006777, unc-41, Putative stoned B-like protein, [RH, Score=355, Expect=4e-104]} {Smed: dd_Smed_v6_6859_0_1, dd_Smed_v6_6859_0_1, [RH, Score=686, Expect=0.0]} {RNA1509_39423} {RNA1310_6760, RNA1509_39423} {RNA1509_39423, RNA815_11749} Mlig455_070496 {REF} {Length: 3566} {Pfam: Adaptor complexes medium subunit family [PF00928.23, score=76.5]} {Human: ENSG00000140022, STON2, stonin 2, [Score=178, Expect=9e-46]} {Mouse: ENSMUSG00000020961, Ston2, stonin 2, [Score=182, Expect=2e-47]} {Dmel: FBgn0016975, stnB, stoned B, [Score=250, Expect=7e-70]} {Celegans: WBGene00006777, unc-41, Putative stoned B-like protein, [Score=235, Expect=1e-64]} {Smed: dd_Smed_v6_6859_0_2, dd_Smed_v6_6859_0_2, [Score=467, Expect=5e-152]} {RNA1509_39423} {RNA1310_6760} {RNA815_11749} |
91. | MligTC455_19616 | 70 | 1.46 | Mlig455_045100 | Neo: - Age: - |
RPH3A | 1.882 | 0.971 | 0.911 | - | - | - | - | Mlig455_045100 {REF} {Length: 2276} {Pfam: C2 domain [PF00168.32, score=141.3]} {Human: ENSG00000089169, RPH3A, rabphilin 3A, [RH, Score=247, Expect=9e-73]} {Mouse: ENSMUSG00000029608, Rph3a, rabphilin 3A, [RH, Score=244, Expect=9e-72]} {Dmel: FBgn0030230, Rph, Rabphilin, [Score=179, Expect=2e-50]} {Celegans: WBGene00004316, rbf-1, Rabphilin-1, [Score=209, Expect=6e-58]} {Smed: dd_Smed_v6_12977_0_1, dd_Smed_v6_12977_0_1, [Score=216, Expect=3e-62]} {RNA1310_30378} {RNA815_36857} |
92. | MligTC455_29119 | 68 | 1.42 | Mlig455_050458 | Neo: - Age: - Region-enriched R2: 5.525/0.01281 |
1.881 | 0.952 | - | - | - | - | 0.929 | Mlig455_050458 {REF} {Length: 624} {RNA1509_53840} {RNA1310_67192} {RNA815_27042} | |
93. | MligTC455_21132 | 10 | 0.22 | Mlig455_019408 | Neo: - Age: - |
1.874 | 0.968 | - | - | - | - | 0.906 | Mlig455_019408 {REF} {Length: 1763} {RNA1310_111763} | |
94. | MligTC455_31163 | 72 | 1.51 | Mlig455_045625 | Neo: - Age: Up-Down-Down |
1.874 | 0.965 | - | - | - | - | 0.909 | Mlig455_045625 {REF} {Length: 1957} {RNA1509_21720} {RNA1310_14760, RNA1509_21720} {RNA1509_21720, RNA815_24583} | |
95. | MligTC455_31104 | 22 | 0.46 | Mlig455_040032, Mlig455_070983 | Neo: - Age: - |
SYT17 | 1.869 | 0.963 | - | - | - | - | 0.906 | Mlig455_040032 {REF} {Length: 2712} {Pfam: C2 domain [PF00168.32, score=79.2]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=127, Expect=1e-30]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=126, Expect=1e-30]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=88.6, Expect=2e-18]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=94.0, Expect=1e-20]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [Score=96.7, Expect=3e-21]} {RNA1310_17303} Mlig455_070983 {REF} {Length: 1947} {Pfam: C2 domain [PF00168.32, score=79.2]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=127, Expect=1e-30]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=126, Expect=1e-30]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=88.6, Expect=2e-18]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=94.0, Expect=1e-20]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [Score=96.7, Expect=3e-21]} {RNA1310_17303} |
96. | MligTC455_17218 | 37 | 0.78 | Mlig455_053853 | Neo: - Age: - |
1.866 | 0.973 | - | - | - | - | 0.893 | Mlig455_053853 {REF} {Length: 1743} {RNA1310_61921} | |
97. | MligTC455_49334 | 86 | 1.78 | Mlig455_037751 | Neo: - Age: - |
1.861 | 0.970 | - | - | - | - | 0.891 | Mlig455_037751 {REF} {Length: 708} {RNA1509_25826} {RNA1310_47741} {RNA815_23874} | |
98. | MligTC455_16874 | 38 | 0.8 | Mlig455_028170 | Neo: - Age: - |
KCNK18 | 1.86 | 0.968 | - | - | - | - | 0.892 | Mlig455_028170 {REF} {Length: 2452} {Pfam: Ion channel [PF07885.18, score=103.1]; Protein of unknown function (DUF3112) [PF11309.10, score=20.2]} {Human: ENSG00000186795, KCNK18, potassium two pore domain channel subfamily K member 18, [Score=96.7, Expect=1e-21]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=101, Expect=2e-23]} {Dmel: FBgn0033257, sand, sandman, [Score=129, Expect=2e-33]} {Celegans: WBGene00006680, twk-28, TWiK family of potassium channels, [Score=144, Expect=3e-38]} {Smed: dd_Smed_v6_17586_0_1, dd_Smed_v6_17586_0_1, [Score=270, Expect=2e-87]} {RNA1509_39975} {RNA1310_18301.1} {RNA815_12440} |
99. | MligTC455_18681 | 61 | 1.27 | Mlig455_069927 | Neo: - Age: Down-Up-Down |
1.856 | 0.963 | - | - | - | - | 0.893 | Mlig455_069927 {REF} {Length: 1526} {RNA1509_58272} {RNA1310_47741} {RNA815_23874} | |
100. | MligTC455_46430 | 62 | 1.29 | Mlig455_057117, Mlig455_069301 | Neo: - Age: - |
GUCY2F | 1.855 | 0.972 | - | - | - | - | 0.883 | Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108} Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181} |